COVID-19. Diagnosis and treatment of lung damage
https://doi.org/10.24835/1607-0763-2020-2-37-49
Abstract
Aim. This publication is devoted to a brief review of the unresolved questions of medical imaging and treatment of COVID-19.
Materials and methods. The analysis of publications for the first quarter of 2020 on radiation diagnosis and treatment of COVID-19 with an emphasis on morpho-radiological comparisons was performed.
Results. It was established that CT can be used for the initial “sorting” of patients in determining the need and conditions of hospitalization, but in the future, often leads to disagreement among pulmonologists and radiologists in assessing the dynamics of the development of the disease. In most patients with COVID-19, the pathomorphological and radiological patterns indicate the formation of the acute phase of diffuse alveolar damage, transforming into organizing pneumonia with typical CT manifestations. However, to date there are no established opinions on the management of patients with corresponding lung lesions.
Conclusion. The literature data on the peculiarities of the pathomorphological and radiological patterns of COVID-19 COVID-19 justify the advisability of using corticosteroids in the treatment of this disease.
About the Authors
A. L. YudinRussian Federation
Andrey L. Yudin – Doсt. of Sсi. (Med.), professor, professor, head of radiology department
house 1, Ostrivityanova str., Moscow, 117997
Yu. A. Abovich
Russian Federation
Yulia A. Abovich – Cand. of Sci. (Med.), associate professor of radiology department; radiologist of radiology department
house 1, Ostrivityanova str., Moscow, 117997;
Nizhnyaya Pervomayskaya str., 70, Moscow, 105203
E. A. Yumatova
Russian Federation
Elena A. Yumatova – Cand. of Sci. (Med.), associate professor, radiology department
house 1, Ostrivityanova str., Moscow, 117997
O. Yu. Bronov
Russian Federation
Oleg Yu. Bronov – Cand. of Sci. (Med.), head of radiology department
Nizhnyaya Pervomayskaya str., 70, Moscow, 105203
References
1. Zhao W., Zhong Zh., Xie Х., Yu Q., Liu J. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. Am. J. Roentgenol. 2020; 214: 1072–1077. http://doi.org/10.2214/AJR.20.22976
2. Hosseiny M., Kooraki S., Gholamrezanehad A., Reddy S., Myers L. Radiology perspective of coronavirus disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and Middle East respiratory syndrome. Am. J. Roentgenol. 2020;214:1078–1082.
3. Hosseiny M., Kooraki S., Gholamrezanezhad A., Reddy S., Lee M. Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. Am. J. Roentgenol. 2020;214:1078–1082. http://doi.org/10.2214/AJR.20.22969
4. Guan W., Liu J., Yu Ch. CT Findings of Coronavirus Disease (COVID-19) Severe Pneumonia. Am. J. Roentgenol. 2020; 214:W85–W86. http://doi.org/10.2214/AJR.20.23035
5. Huang G., Gong T., Wang G., Wang J., Guo X., Cai E., Li S., Li X., Yu Y., Lin L. Timely Diagnosis and Treatment Shortens the Time to Resolution of Coronavirus Disease (COVID-19) Pneumonia and Lowers the Highest and Last CT Scores From Sequential Chest CT. Am. J. Roentgenol. 2020; 215: 1–7. http://doi.org/10.2214/AJR.20.23078
6. Zhao W., Zheng Z., Xie X., Qizhi Y., Liu J. CT scans of patients with 2019 novel coronavirus (COVID-19) pneumonia. Theranostics. 2020; 10: 4606–4613. https://doi.org/10.7150/thno.45016
7. Hope M.D., Raptis C.A., Shah A. A role for CT in COVID-19? What data really tell us so far. Lancet. 2020; 395:1189– 1190. https://doi.org/10.1016/s0140-6736(20)30728-5
8. Speranskaia A.A., Novikova L.N., Baranova O.P., Vasilieva M.A. Radiology of viral pneumonia. Vestnik Rentgenologii i Radiologii = Russian Journal of Radiology. 2016; 97 (3): 149–156. http://doi.org/10.20862/0042-4676-2016-97-3-149-156. (In Russian)
9. Rosstalnaya A.L., Sabirov D.M., Akalayev R.N., Sharipova V.K., Rosstalnaya M.L., Mamirov A.O. Acute lung injury: issues and remaining challenges (a literature review). Russian Sklifosovsky Journal “Emergency Medical Care”. 2016; 3: 66–72. (In Russian)
10. Cardinal-Fernández P., Lorente J. A., Ballén-Barragán A., Matute-Bello G. Acute Respiratory Distress Syndrome and Diffuse Alveolar Damage. New Insights on a Complex Relationship. Ann. Am. Thorac. Soc. 2017; 14 (6): 844– 850. http://doi.org/10.1513/annalsats.201609-728ps
11. Khilnani GC, Hadda V. Corticosteroids and ARDS: A review of treatment and prevention evidence. Lung India. 2011; 28 (2): 114–119. http://doi.org/10.4103/0970-2113.80324
12. Mitchell O.J.L., Sternschein R., Kunzler N., Zhao Y., Uppal A. Acute Interstitial Pneumonia Versus Acute Respiratory Distress Syndrome: Is There a Difference? American Journal of Respiratory and Critical Care Medicine 2020;201:A5884
13. Cordier J.F. Organising pneumonia. Thorax. 2000; 55 (4): 318–328 http://doi.org/10.1136/thorax.55.4.318
14. Avdeev S.N., Chernyaev A.L. Organized pneumonia. Atmosphere. Pulmonology and Allergology. 2011; 1: 6–13. (In Russian)
15. Beasley M. The pathologist’s approach to acute lung injury. Arch. Pathol. Lab. Med. 2010; 134 (5): 719–727. http://doi.org/10.1043/1543-2165-134.5.719
16. Hwang D.M., Chamberlain D.W., Poutanen S.M., Low D.E., Asa S.L., Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod. Pathol. 2005; 18 (1): 1–10. https://doi.org/10.1038/modpathol.3800247
17. Copin M., Parmentier E., Duburcq T. et al. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med. Published online: 23 April 2020. https://doi.org/10.1007/s00134-020-06057-8
18. Kim J., Doo K., Jang H. Acute fibrinous and organizing pneumonia: Imaging features, pathologic correlation, and brief literature review. Radiol Case Rep. 2018; 13 (4): 867–870. http://doi.org/10.1016/j.radcr.2018.04.028
19. Samsonova M.V. Chernyaev A.L. Mikhaleva L.M. Zairatyants O.V. Mishnev O.D. Pathological lung anatomy with COVID-19. http://www.patolog.ru/sites/default/files/mv_ samsonova_covid-19_.pdf (In Russian)
20. Lee N., Allen C., Hui D. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J. Clin. Virol. 2004; 31 (4): 304–309. http://doi.org/10.1016/j.jcv.2004.07.006
21. Wang Y, Jiang W, He Q, Wang C, Wang B, Zhou P et al. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia. Signal Transduct. Target Ther. 2020; 5 (1): 57. http://doi.org/10.1038/s41392-020-0158-2
22. Zhou Y., Qin Y., Lu Y. Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial. Chin. Med. J. (Engl). 2020; 133 (9): 1080–1086. http://doi.org/10.1097/CM9.0000000000000791
23. Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA. Intern Med. 2020 Mar 13: e200994. http://doi.org/10.1001/jamainternmed.2020.0994.
24. Fadel R., Morrison A., Vahia A., Smith Z., Chaudhry Z., Bhargava P. Early Short Course Corticosteroids in Hospitalized Patients with COVID-19. COVID-19 Management Task Force. medRxiv 2020.05.04.20074609. https://doi.org/10.1101/2020.05.04.20074609
25. EVMS Critical Care COVID-19 Management Protocol 05-14-2020 | evms.edu/covidcare (EVMS COVID website: https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_ COVID-19_Protocol.pdf
Review
For citations:
Yudin A.L., Abovich Yu.A., Yumatova E.A., Bronov O.Yu. COVID-19. Diagnosis and treatment of lung damage. Medical Visualization. 2020;24(2):37-49. (In Russ.) https://doi.org/10.24835/1607-0763-2020-2-37-49